NewsRX Health & Science
The risk of death from all-causes and cardiovascular diseases among people with type 2 diabetes is more than twice that of people of a similar age without diabetes. Logically, if lifestyle interventions reduce the risk of diabetes they should also reduce the excess risk of death, particularly from cardiovascular disease. However, without proof that lifestyle interventions will lead long-term health benefits such as reducing death rates in high-risk people, it is difficult for doctors to recommend it to their patients as an effective preventive therapy.
In new research published in The Lancet Diabetes & Endocrinology journal, Professor
The investigators enrolled 438 patients assigned to intervention clinics, and 138 patients were assigned to control clinics. The study intervention lasted for 6 years, and patients were then followed up for 23 years. At the end of the follow up period, cumulative incidence of death from cardiovascular disease was 11•9% in the lifestyle intervention group, versus 19•6% in the control group, and death from all causes was 28•1% in the lifestyle group versus 38•4% in the control group. The difference between groups for both outcomes was statistically significant.
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Articles featured in Life Extension Daily News are derived from a variety of news sources and are provided as a service by Life Extension. These articles, while of potential interest to readers of Life Extension Daily News, do not necessarily represent the opinions nor constitute the advice of Life Extension.